Sleep Problems
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
1 programUnderstanding Sleep Problems in Children With Autism Spectrum DisorderN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Neurim PharmaceuticalsCircadin 2 mg
Oregon TherapeuticsUnderstanding Sleep Problems in Children With Autism Spectrum Disorder
Clinical Trials (2)
Total enrollment: 74 patients across 2 trials
Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
Start: Mar 2013Est. completion: Apr 201416 patients
Phase 1Completed
NCT00691080Oregon TherapeuticsUnderstanding Sleep Problems in Children With Autism Spectrum Disorder
Understanding Sleep Problems in Children With Autism Spectrum Disorder
Start: Sep 2007Est. completion: Nov 201158 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.